OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1422-1433
Open Access | Times Cited: 5
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1422-1433
Open Access | Times Cited: 5
Showing 5 citing articles:
Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
Velma Ganga Reddy, Isabella S. Krider, Erick T. M. Alves, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 5999-6026
Open Access | Times Cited: 6
Velma Ganga Reddy, Isabella S. Krider, Erick T. M. Alves, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 5999-6026
Open Access | Times Cited: 6
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer
Yang Li, Yan Fang, Xiaoyu Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 438-466
Open Access | Times Cited: 1
Yang Li, Yan Fang, Xiaoyu Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 438-466
Open Access | Times Cited: 1
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
